Bioclinica Announces AB Cube Has Joined eHealth App xChange

Published on: 

Company News Release

DOYLESTOWN, PA. JULY 17, 2017-Bioclinica®, provider of technology-enabled clinical trial solutions, announced safety software company AB Cube has joined its eHealth App xChange™, an alliance channel within the eHealth Solutions business segment to advance technology innovation across life sciences and healthcare. Under the partnership, AB Cube’s cloud-based pharmacovigilance platform for management of adverse events will become part of Bioclinica’s extensive eHealth App xChange offerings available in the Bioclinica eHealth Cloud™.

“Our eHealth Solutions team is collaborating with highly innovative technology partners around the globe, and in AB Cube we foresee an industry transformation toward a next-generation safety platform that brings simplicity, proven savings and efficiencies with a unique cloud architecture and advanced process automation capabilities,” said Bioclinica President eHealth Solutions Mukhtar Ahmed. Paris-based AB Cube’s safety technology, already selected by more than 300 companies worldwide as their safety platform of choice, has the flexibility to handle any volume of case processing, large or small.

Pharmacovigilance, crucial to an effective drug regulation system and clinical research, is focused on evaluating and monitoring adverse drug reactions and minimizing the risk of harm to patients. The Bioclinica-AB Cube collaboration brings a cloud safety platform along with process automation capabilities to shorten the PV process and maintain compliance with strict worldwide laws, regulations, and guidance.

“We are delighted to partner with Bioclinica on a safety solution that aligns so well with their technology-agnostic philosophy,” said AB Cube CEO Matthieu Doresse. “As a true SaaS offering where everyone uses the same version and is informed well in advance of automatic system updates, the platform is a huge leap forward in terms of ease of implementation and maintenance as well as decreased total cost of ownership.” Additionally, the software easily scales up or down dependent on an organization’s needs, circumstances, case processing volume fluctuations, and other variables that otherwise would be costly and difficult to manage.

AB Cube’s safety system is available with optional hosting, support, and professional consulting services provided by Bioclinica, such as business process and change management. This allows organizations to tap the extensive expertise, resources, and experience within Bioclinica’s Safety & Regulatory Solutions division, including help desks.

Customers using AB Cube’s solutions can employ Bioclinica’s end-to-end Pharmacovigilance as a Service (PVaaS) model where Bioclinica is responsible for management of underlying applications and infrastructure. Additionally, Bioclinica may tackle the case processing, performed by drug safety specialists experienced in handling more than 700,000 Individual Case Safety Report (ICSR) cases annually for customers operating on a variety of PV systems.


Bioclinica’s PVaaS Model includes: 

  • Infrastructure and application hosting

  • System implementation

  • Application and infrastructure support

  • Case processing

  • Aggregate reporting

  • Literature review

  • Signal management

“No matter the technology currently in place, PVaaS is a great alternative for companies seeking to outsource safety infrastructure, resources, and case processing to dedicated safety and regulatory experts in a proven, cost-effective model,” Ahmed commented. “We welcome discussions to assist organizations in achieving their safety needs with a streamlined system and supporting services for efficiency, quality and cost benefits.”

Bioclinica’s expansion of partners within its App xChange is part of a continuum in the eHealth Solutions business segment to make it easier for regulated industries to access technology and services while also helping organizations evolve to keep pace with change.

To learn more about Bioclinica, eHealth Solutions, App xChange and its many innovative partners, visit . Get clinical trial insights in the Bioclinica blog and the latest Company news on Bioclinica LinkedIn and Twitter channels.